Therefore, even when Myc is not the driver oncogenic lesion, it acts as an integrator of extracellular and intracellular oncogenic signals, an attribute that makes it a ‘most wanted’ target for the treatment of cancer [31]. The gene discussed is MYC; the disease is cancer.